Geneos Wealth Management’s CapForce IBD 50 ETF FFTY Stock Holding History

Geneos Wealth Management’s Portfolio FFTY Stock Details FFTY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-178	Closed	-$6K	–	2508
2019 Q2	$6K	Hold	178	–	–	﹤0.01%	2066
2019 Q1	$5K	Buy	+178	New	+$5.6K	﹤0.01%	2029
2018 Q4	–	Sell	-878	Closed	-$33K	–	2416
2018 Q3	$33K	Buy	878 +27	+3%	+$993	﹤0.01%	1353
2018 Q2	$29K	Buy	851 +55	+7%	+$1.92K	﹤0.01%	1297
2018 Q1	$26K	Buy	796 +490	+160%	+$16.7K	﹤0.01%	1274
2017 Q4	$10K	Buy	+306	New	+$10.2K	﹤0.01%	1628

Other funds holding FFTY

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CPIG

Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

CCWA

CLA (CliftonLarsonAllen) Wealth Advisors Minneapolis, Minnesota $7.61B AUM 16.44% 1-Year Est. Return

FAAS

First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return

Geneos Wealth Management's FFTY Position: Q3 2019 in Review

Geneos Wealth Management sold out of CapForce IBD 50 ETF (FFTY) in Q3 2019, closing a stake of 178 shares — an estimated $6K sold.

Geneos Wealth Management first reported a position in FFTY in Q4 2017 and held it in 6 quarters. The position peaked at $33K in Q3 2018. 70 funds tracked by Wall St. Rank hold FFTY as of Q3 2019.

Geneos Wealth Management reported no remaining CapForce IBD 50 ETF position as of Q3 2019 after selling out during the quarter.
Geneos Wealth Management sold 178 CapForce IBD 50 ETF shares in Q3 2019, an estimated $6K.
Geneos Wealth Management first reported a position in CapForce IBD 50 ETF in Q4 2017 and held it in 6 quarters.
Geneos Wealth Management's CapForce IBD 50 ETF position peaked at $33K in Q3 2018.
70 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q3 2019.

Based on Geneos Wealth Management's 13F filing for Q3 2019, filed 7 Sep 2021.